These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 16495795)

  • 1. Donor-specific antibodies arising after kidney transplantectomy: priming or memory?
    Doxiadis II; Claas FH
    Transplantation; 2006 Feb; 81(4):509-10. PubMed ID: 16495795
    [No Abstract]   [Full Text] [Related]  

  • 2. Frequent but late donor-directed antibody formation after kidney transplantectomy within one month after grafting.
    Lenaers J; Christiaans M; van Heurn E; van Hooff H; van den Berg-Loonen E
    Transplantation; 2006 Feb; 81(4):614-9. PubMed ID: 16495811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Donor-directed HLA antibodies before and after transplantectomy detected by the luminex single antigen assay.
    Billen EV; Christiaans MH; Lee J; van den Berg-Loonen EM
    Transplantation; 2009 Feb; 87(4):563-9. PubMed ID: 19307795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of non-donor-specific HLA antibodies after kidney transplantation: frequency and clinical implications.
    Briggs D; Zehnder D; Higgins RM
    Contrib Nephrol; 2009; 162():107-16. PubMed ID: 19001818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Donor-specific antibody detection for diagnosis of antibody-mediated rejection in kidney transplantation.
    Gautreau C; Suberbielle C; Andrade J; Charron D
    Clin Transpl; 2006; ():502. PubMed ID: 18365411
    [No Abstract]   [Full Text] [Related]  

  • 6. Pre-formed donor-specific alloantibodies (DSA) detected only by luminex technology using HLA-coated microspheres and causing acute humoral rejection and kidney graft dysfunction.
    Muro M; Llorente S; Gónzalez-Soriano MJ; Minguela A; Gimeno L; Alvarez-López MR
    Clin Transpl; 2006; ():379-83. PubMed ID: 18365392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How much donor human leukocyte antigen-specific antibody is too much for a renal transplant?
    Vaughan R; Shaw O
    Transplantation; 2008 Apr; 85(8):1081-2. PubMed ID: 18431224
    [No Abstract]   [Full Text] [Related]  

  • 8. Renal graft loss in recipients with at least one year of function and donor specific antibody (DSA).
    Cicciarelli J; Shah T; Koss M; Houston K; Narahghi R
    Clin Transpl; 2006; ():539-40. PubMed ID: 18365421
    [No Abstract]   [Full Text] [Related]  

  • 9. Detection and analysis of HLA class I and class II specific alloantibodies in the sera of dialysis recipients waiting for a renal retransplantation.
    Barocci S; Valente U; Nocera A
    Clin Transplant; 2007; 21(1):47-56. PubMed ID: 17302591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-transplant donor-specific antibody production and graft outcome in kidney transplantation: results of sixteen-year monitoring by flow cytometry.
    Piazza A; Poggi E; Ozzella G; Borrelli L; Scornajenghi A; Iaria G; Tisone G; Adorno D
    Clin Transpl; 2006; ():323-36. PubMed ID: 18365387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Public epitope specificity of HLA class I antibodies induced by a failed kidney transplant: alloantibody characterization by flow cytometric techniques.
    Piazza A; Poggi E; Ozzella G; Borrelli L; Monaco PI; Scornajenghi A; Tisone G; Adorno D
    Transplantation; 2006 May; 81(9):1298-305. PubMed ID: 16699458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of HLA class I specific antibodies in patients with failed allografts.
    Mao Q; Terasaki PI; Cai J; El-Awar N; Rebellato L
    Transplantation; 2007 Jan; 83(1):54-61. PubMed ID: 17220791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of anti-HLA and donor-specific antibodies in long-term renal graft survival.
    Saidman S
    Transplant Proc; 2007 Apr; 39(3):744-6. PubMed ID: 17445587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of class II transactivator and interleukin-6 polymorphisms on the production of antibodies to donor human leucocyte antigen mismatches in renal allograft recipients.
    Martin J; Worthington J; Harris S; Martin S
    Int J Immunogenet; 2009 Aug; 36(4):235-9. PubMed ID: 19523152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acceptable donor-specific antibody levels allowing for successful deceased and living donor kidney transplantation after desensitization therapy.
    Reinsmoen NL; Lai CH; Vo A; Cao K; Ong G; Naim M; Wang Q; Jordan SC
    Transplantation; 2008 Sep; 86(6):820-5. PubMed ID: 18813107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alloantibodies and the outcome of cadaver kidney allografts.
    Vasilescu ER; Ho EK; Colovai AI; Vlad G; Foca-Rodi A; Markowitz GS; D'Agati V; Hardy MA; Ratner LE; Suciu-Foca N
    Hum Immunol; 2006 Aug; 67(8):597-604. PubMed ID: 16916655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical relevance of preformed HLA donor-specific antibodies in kidney transplantation.
    Lefaucheur C; Suberbielle-Boissel C; Hill GS; Nochy D; Andrade J; Antoine C; Gautreau C; Charron D; Glotz D
    Contrib Nephrol; 2009; 162():1-12. PubMed ID: 19001809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and anti-HLA antibody profile of nine renal transplant recipients with failed grafts: donor-specific and non-donor-specific antibody development.
    Rebellato LM; Ozawa M; Verbanac KM; Catrou P; Haisch CE; Terasaki PI
    Clin Transpl; 2006; ():241-53. PubMed ID: 18365382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Graft loss in three patients with donor-specific antibody (DSA).
    Qasi Y; Hermes M; Cicciarelli J
    Clin Transpl; 2006; ():541. PubMed ID: 18365422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retrospective antibody analysis of thirty patients with kidney graft failure.
    Kinukawa T; Kato M; Terasaki PI; Ozawa M
    Clin Transpl; 2006; ():291-303. PubMed ID: 18365385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.